Skip to content
HowShorted

CytomX Therapeutics, Inc. short interest in 2026

In 2026, CytomX Therapeutics, Inc.'s disclosed short interest ran from 9.47% of shares outstanding on 15 Jan 2026 to 17.73% on 15 Sep 2026, a change of +8.26 percentage points. The year's high was 18.52% on 15 Jul 2026 and its low 8.70% on 30 Jan 2026, averaging 13.85% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.93 days on 14 Aug 2026. Full history: CytomX Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for CytomX Therapeutics, Inc. in 2026

2026 in figures

Start of year
9.47% (15 Jan 2026)
End of year
17.73% (15 Sep 2026)
Change
+8.26 pp
High
18.52% (15 Jul 2026)
Low
8.70% (30 Jan 2026)
Average
13.85%
Highest days to cover
15.93 (14 Aug 2026)
SEC filings marked
6

Every report in 2026

CytomX Therapeutics, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 20269.47%7.49
30 Jan 20268.70%3.33
13 Feb 20269.97%4.66
27 Feb 202611.08%8.03
13 Mar 202612.00%7.10
31 Mar 202612.95%1.1410-K filed, results (8-K)
15 Apr 202616.17%5.41
30 Apr 202613.66%8.44
15 May 202614.30%10.3210-Q filed, results (8-K)
29 May 202613.19%9.31
15 Jun 202614.06%8.65
30 Jun 202616.34%4.32
15 Jul 202618.52%10.38
31 Jul 202616.11%11.78
14 Aug 202615.89%15.9310-Q filed, results (8-K)
31 Aug 202615.38%11.81
15 Sep 202617.73%9.29

See also: CytomX Therapeutics, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.